Use of botulinum toxin type A in management of adult spasticity--a European consensus statement

J Rehabil Med. 2003 Mar;35(2):98-9. doi: 10.1080/16501970306112.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Botulinum Toxins, Type A / adverse effects
  • Botulinum Toxins, Type A / therapeutic use*
  • Consensus
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Europe
  • Female
  • Humans
  • Injections, Intramuscular
  • Male
  • Muscle Spasticity / diagnosis
  • Muscle Spasticity / drug therapy*
  • Muscle Spasticity / rehabilitation
  • Risk Assessment
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Botulinum Toxins, Type A